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Summary
OBJECTIVE: Decision-making capacity (DMC) is an in-
dispensable prerequisite for patients’ informed consent and
therefore directly related to the right to self-determination.
In view of this ethical implication, valid and reliable as-
sessment of DMC is essential to best practice. In general,
and with particular regard to the Swiss context, little is
known about healthcare practitioners’ knowledge of and at-
titudes to the concept of DMC, or about their assessment
practice. The present study aims to close this gap.
METHOD: A randomised representative sample of 3,500
physicians, including all specialisms and from all parts of
Switzerland, were contacted by mail and invited to com-
plete a survey questionnaire, which was specifically de-
signed for the purpose of the study.
RESULTS: A total of 763 questionnaires were included
for analysis (response rate: 22.15%). Physicians diverged
in their general understanding of DMC as either a dicho-
tomous or a gradual concept, and in relation to the con-
ceptual challenges of decisional relativity and risk-relativ-
ity. Along with cognitive abilities, emotional, intuitive, or
evaluative factors were acknowledged as important criter-
ia. DMC was most often assessed implicitly: explicit as-
sessments, if conducted, depended mainly on unstructured
interviews. A discrepancy was identified between physi-
cians’ perceptions of responsibility and qualification, in-
dicating a related need for more guidance and training.
CONCLUSION: The conceptual and practical challenges
of DMC are far from being resolved. There is a clear need
for more guidance in this area in the form of guidelines,
tools, and training.
Key words: Decision-making capacity; competence;
assessment; attitudes; knowledge; physicians; ethics;
guidelines; informed consent; self-determination
Introduction
Decision-making capacity (DMC) is among the prerequis-
ites for valid consent to medical treatment. From an ethical
perspective, DMC judgements reflect the tension between
the moral duty to respect the autonomy of the individual
who is capable of making his or her own decision and the
need to protect decisionally incapable persons [1]. Evalu-
ations of DMC seek to balance these different moral con-
cerns, and to set the course for appropriate and responsible
action. The issue is especially relevant in the case of vul-
nerable persons, such as those with cognitive and mental
impairments or in precarious situations – for example, end
of life situations that may often involve existential,
medical-ethical decisions [2]. It seems essential, then, to
first seek clarity with respect to the definition and con-
stitutive elements of the concept, and second, to be able to
reliably and validly assess DMC in vulnerable patients.
From a conceptual perspective, a range of challenges arise
[3]. One very general issue concerns the distinction
between dichotomous and gradualist notions of DMC, both
of which seem valid from different viewpoints. If emphasis
is put on the actions guiding clinical judgment, it is prefer-
able that DMC be seen as either present or absent, with a
clear threshold. However, if emphasis is placed on under-
lying mental abilities, which can in turn be more or less in-
tact, a gradualist understanding may be more appropriate
[1].
In terms of mental abilities, the delineation of relevant cri-
teria is also conceptually challenging. The following four
criteria have been proposed [4]: (1.) evidencing a choice
refers to the ability of the patient to communicate a choice;
(2.) understanding refers to the ability to comprehend
treatment-related information, such as information about
the present disorder, treatment options, and related risks
and benefits; (3.) appreciation refers to the ability to ap-
preciate the nature of the disorder, and the possibility that
treatment could be beneficial (which is distinct from the
understanding standard in that it requires the patient to ap-
ply the information to his or her own situation); and (4.)
reasoning refers to the ability to manipulate information ra-
tionally, using logic to compare the risks and benefits of
treatment alternatives. However, it remains a matter of de-
bate as to whether these criteria are appropriate and suffi-
cient: they are, for instance, criticised for being unduly fo-
cused on cognitive aspects (e.g., [5–7]).
There is more agreement around the challenge of decision-
al relativity. It is widely accepted that DMC is assessed as
a function of a particular decision or situation, which im-
plies that a patient may be capable of making a particular
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treatment decision but is less capable of assessing another
[1]. DMC may vary over time due to fluctuating mental
abilities [8], and the notion of relativity may also apply to
the risk that accompanies a certain decision. A risk-relat-
ive assessment of DMC means an evaluation of capacity
with due consideration of the risk-benefit profile related to
a certain decision, using different or more stringent criter-
ia in terms of mental abilities according to the level of risk
associated with the patient’s choice. For example, if the
treatment choice carries only a minor risk, it may be suf-
ficient that the patient understands the given information;
if a high-risk option is chosen, s/he must additionally be
able to weigh the given information in light of his or her
own values. Taking risk-relativity into account in evaluat-
ing DMC is controversial and constitutes one of the most
complex challenges to the concept (e.g., [9, 10]).
In addition to these conceptual aspects, DMC assessments
are also challenging from a practical perspective, involving
questions of how to translate conceptual concerns into a
feasible, valid, and reliable assessment procedure, and how
such procedures should optimally be formulated.
Scholars have taken steps both to clarify the conceptual
challenges and to address practical issues by, for example,
developing and validating standardised assessment tools
(for an overview see [11]). Additionally, DMC has been
investigated in different patient populations [12]. By con-
trast, relatively little is known about the assessing clini-
cians or their knowledge, attitude and approach to the
concept and the assessment of DMC. However, the few
existing studies focused primarily on these aspects have
shown that misunderstandings and knowledge deficits are
prevalent among healthcare practitioners, indicating that
continuing education and training is needed in this area
[13]. At present, there are no existing studies that provide
information on how physicians in Switzerland approach the
conceptualisation and evaluation of DMC. For this reas-
on, the aim of the present study was to augment this line
of research in an attempt to shed light on the situation in
Switzerland. The following clusters of research questions
guided the survey.
1. How do physicians perceive their responsibility and
qualifications for conducting DMC evaluations?
2. What is the current state of physicians’ attitudes and
knowledge of DMC in terms of general conceptual
understanding, relevant mental abilities, decisional
relativity, and risk-relativity?
3. How is DMC dealt with in clinical practice? Which
patient behaviours and patient groups challenge
DMC? Which complicating factors do physicians
encounter? And what kinds of interventions and
strategies do physicians use to enhance patients’
capacity?
4. What kind of DMC assessment procedures do
physicians conduct?
5. Do physicians request DMC assessment tools and
official guidelines, or do they seek more extensive
education and training?
Methods
Study design, procedure, and sample
The present survey was part of the study “Decision-making
incapacity at the end of life and its assessment in Switzer-
land”, funded within the National Research Programme
NRP 67 End of Life of the Swiss National Science Founda-
tion, and conducted in cooperation with the Swiss Academy
of Medical Sciences (SAMS). The study protocol was ap-
proved by the ethical review committee of every Swiss can-
ton.
The research questions were addressed within a represent-
ative cross-sectional survey of physicians in Switzerland.
The main survey questionnaire was developed specific-
ally for the purpose of the present study. At each stage of
the project, a multi-disciplinary advisory board comprising
physicians, psychologists, ethicists, and lawyers was con-
sulted (see Acknowledgements section).
Hard copies of the survey questionnaire were sent by mail.
Participants had the option of filling in a paper-and-pencil
version of the questionnaire or using a link to an online
version. Data collection lasted for six months from June to
November 2013. As a reward for participation, all respond-
ents were included in a prize draw for 15 book vouchers of
100 Swiss Francs.
The study was conducted among senior physicians prac-
tising in Switzerland as accredited medical specialists. A
randomised representative sample of 3,500 physicians, in-
cluding all specialisms and from all parts of Switzerland
(German, French, and Italian), was drawn by the Swiss
Medical Association FMH, corresponding to approxim-
ately 11% of physicians in Switzerland [14]. Fifteen sub-
jects were not included, either because they were on the
project advisory board or had taken part in the pilot study.
Survey questionnaire
A first version of the survey questionnaire was developed,
based on the research questions of the present study. This
first version was discussed within the advisory group, the
central ethics committee of the SAMS, and in two focus
group meetings, with general practitioners, psychiatrists,
and neurologists. After revision, a second version was dis-
cussed with a biostatistician and again presented to the
central ethics committee of the SAMS. After a further
(second) revision, the third version of the questionnaire
was used for a pilot study among 86 Swiss physicians, from
every specialism, in German-speaking Switzerland. The
comments and suggestions of these respondents formed the
basis for a third revision of the questionnaire, which led to
the final version used in the main survey. This final ver-
sion was then translated from German to French by a pro-
fessional translator from the SAMS. Physicians from the
Italian-speaking part of Switzerland could choose to fill in
either the German or French version of the survey (ques-
tionnaire versions are available on request from the au-
thors).
Statistics
In addition to descriptive statistics, nonparametric testing
was used to compare physician groups (Mann-Whitney
Test) or variables (Wilcoxon Signed-Ranks Test), or to de-
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tect correlations (Spearman). Significance was assigned at
the five percent level. Data were analysed using SPSS 19.
Results
The questionnaire was completed by 772 physicians, which
corresponds to a response rate of 22.15%. Women showed
a response rate of 25.87%, and the rate for men was
20.46%. The response rate was 23.32% among German-
speaking participants, and 19.08% among French-speaking
participants. The majority responded via the paper-and-
pencil version (90.5%); only 9.5% responded online. Since
physicians who did not work as clinicians were excluded
(n = 9), analysis was conducted with a final sample of
763. Table 1 shows the socio-demographic variables of the
sample.
Responsibility and qualification
In terms of responsibility and qualification, the results yiel-
ded the following crosstable (table 2), showing a difference
on these two aspects. In essence, 35.8% (n = 167) of those
who indicated that they feel very responsible for assessing
DMC (61.3%, n = 468) also felt that they were surely qual-
ified enough for so doing.
Additional mean rank comparisons (Mann-Whitney tests)
found that psychiatrists and psychotherapists not only feel
more responsible (p <0.001) but also more qualified (p
<0.001) than other specialists. Child and adolescent psychi-
atrists, however, only feel significantly more responsible (p
<0.05).
A Spearman correlation analysis showed (although with a
small coefficient) that the more experienced physicians are,
the more qualified they perceive themselves to assess DMC
(rs = 0.15; p <0.001; one-tailed).
Attitudes and knowledge
Asked to indicate whether DMC is a dichotomous concept
(DMC yes/no) or a gradual concept (DMC more or less),
a minority favoured the dichotomous notion (22.4%, n =
171), but most selected a gradual conception of DMC
(73.9%, n = 564). A few felt indecisive with respect to this
question (3.3%, n = 25).
Concerning criteria for DMC with respect to mental abil-
ities, the classical cognitive standards (understanding, ap-
preciation, reasoning, and evidencing a choice) were con-
sidered most important – specifically, more important than
engaging emotionally and intuitively in the decision-mak-
ing process, and more important than reasoning about the
given information in the light of one’s coherent set of val-
ues (p <0.001, Wilcoxon Signed-Ranks Test). The non-
cognitive factors were nevertheless regarded as rather or
very relevant by most physicians, including emotional par-
ticipation (69.1%, n = 527), reference to one’s biography,
experiences, and intuitive knowledge (71.2%, n = 543), and
reference to one’s values (89.2%, n = 681).
Since other factors besides knowledge about patients’ men-
tal abilities contribute to DMC evaluations [15], physicians
were also asked to indicate to what extent these may have
an impact. These factors are listed below in descending or-
der of importance, with percentage and number of physi-
cians who quoted the factors as rather or very important:
psychopathological status (84.5%, n = 644); medical con-
text, for example, urgency of treatment (75%, n = 572);
complexity of treatment alternatives, for example, risks and
benefits (74.3%, n = 567), information/statements of pa-
tient’s next of kin (69.7%, n = 532); somatic status (62.1%,
n = 474); therapeutic relationship with the physician
(52.6%, n = 401); social context, for example, extent of
patient’s social support (50.3%, n = 384); and physician’s
own set of values (26.5%, n = 202).
A vignette was presented to investigate whether or not
physicians assess DMC relative to the specific decision at
hand (decisional relativity). The scenario in question in-
volved obtaining consent to two different interventions that
were discussed during the same consultation: (1.) an ad-
justment of medication, and (2.) a minor surgical interven-
Table 1: Socio-demographic variables (n = 763, FMH physician statistics 2012/2013 [14, 23]).
Survey sample Swiss physician statistics
Age (in years) M = 48.2 (SD = 8.03) M = 48.8
Sex Female
Male
33%
66.3%
38.6%
61.4%
Field of practice General practice
Specialist practice
Hospital
Other
4.1%
16%
83.7%
5.9%
Outpatient setting
Inpatient setting
Other
52.8%
45.5%
1.7%
Level of employment full-time
Part-time
27.1%
72.1%
36%
64%
Clinical experience (in years) M = 21 (SD = 8.14) (No data available)
M = mean; SD = standard deviation.
Table 2: Cross tabulation: Responsibility and qualification for conducting DMC evaluations.
Qualification
Not qualified enough Rather not qualified
enough
Rather qualified
enough
Surely qualified
enough
TOTAL**
Not responsible 72.2%* 27.8%* – – 2.4%
Rather not responsible 11.1%* 73%* 14.3%* 1.6%* 8.3%
Rather responsible 1.9%* 31.8%* 65.4%* 0.9%* 27.7%
Very responsible 0.2%* 8.1%* 55.9%* 35.8%* 61.3%
Responsibility
TOTAL** 3.3% 20.4% 53.7% 22.3%
* % within gradation of responsibility; ** % within total sample.
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tion. The results showed that 58.6% (n = 447) conducted
discrete DMC assessments for each of the two interven-
tions, whereas 40.2% (n = 307) evaluated DMC only for
the first intervention and extrapolated to the second inter-
vention from this first judgement of DMC.
In terms of risk-relativity, a high proportion of physicians
indicated, on a generally formulated item, that severity of
consequence of a medical decision is rather relevant or
very relevant for how they evaluate DMC (73.7%, n = 562).
By contrast, the analysis of the risk-relativity case vignette
(see table 3, chemotherapy vignette) showed that almost
as many did not consider risk-relativity, and would apply
equally stringent criteria in terms of mental abilities both
in cases of consent to or refusal of chemotherapy (66.8%,
n = 510). Only 31.7% (n = 242) demanded more stringent
standards in the case of treatment refusal, which is con-
sidered to be the more risky option. Furthermore, almost
all physicians who stated that the consequences of a med-
ical decision are not at all relevant for DMC evaluations
on the general item also indicated that they would apply
equal standards for consent to treatment and treatment re-
fusal in the vignette (92.2%, n = 59). Conversely, less than
half of those who regarded consequences as very relevant
for DMC evaluations on the general item applied higher
standards for treatment refusal in the vignette (41%, n =
125). Of those physicians, 58% (n = 177) did not conform
to risk-relativity.
Another vignette, on assisted suicide, yielded comparable
results (table 3, assisted suicide vignette). Here, a majority
of physicians applied equally stringent criteria in both
cases (57.9%, n = 442). Only 36.2% (n = 276) asked for
higher standards concerning mental abilities in the case of
assisted suicide in comparison to treatment refusal (forgo-
ing chemotherapy). Moreover, 16.4% (n = 125) stated that
they would have to be personally convinced that assisted
suicide was the best available option for the patient as a cri-
terion for deeming the patient capable.
Clinical practice
Physicians were asked to indicate to what extent different
patient behaviours raise the question of DMC. These beha-
viours are listed in descending order, with percentage and
number of physicians who would in most cases or always
be alerted by the behaviour: a patient is at immediate risk
of harming himself or herself or others (87.3%, n = 666); a
patient makes a decision which is incomprehensible to the
physician, for example, if he or she demands assisted sui-
cide in the case of a treatable condition (81.5%, n = 622);
a patient repeatedly changes his or her mind concerning
the decision (68.9%, n = 525); a patient is desperate and
consents immediately and uncritically to every treatment
that has been proposed to him or her (64%, n = 488); a
patient communicates that he or she does not care about
the decision (63.3%, n = 483); a patient cedes every treat-
ment decision to the attending physician or to another per-
son, because he or she does not feel confident to make the
right decision (60%, n = 458); and a patient does not agree
with the physician’s treatment recommendation (43.3%, n
= 330).
With regard to patient groups, a variety of diagnoses and
conditions were presented that are known or expected to be
associated with decision-making incapacity, and physicians
had to state how often they assess DMC in more detail for
each patient group. The conditions are listed in descending
order, with percentage and number of physicians who ex-
amine DMC either often or always in more detail: healthy
elderly persons (44.9%, n = 343); patients at the end of
life (44.4%, n = 339); mild cognitive impairment (44%, n
= 336); Alzheimer’s disease (40.2%, n = 307); medical in-
patients (34.7%, n = 265); unipolar depression (27.6%, n =
210); schizophrenia (24.7%, n =189); Parkinson’s disease
(24.6%, n =187); learning disability (21.8%, n = 166); and
glioma (16.7%, n = 128).
Tables 4 and 5 show which among a given set of com-
plicating factors physicians regard as particularly challen-
ging for DMC evaluations (table 4), and which intervention
strategies for enhancing patients’ DMC they find relevant
as well as feasible in everyday practice (table 5).
Assessment procedure
Physicians were asked to indicate how often they evaluate
DMC implicitly, explicitly or in consultation with special-
ised colleagues (table 6). Analysis shows a significant
mean rank difference between the implicit and explicit ap-
proaches, with the former being more frequent (p <0.001;
Wilcoxon Signed-Ranks Test). Moreover, explicit assess-
Table 3: Case vignettes.
Chemotherapy
A patient has to decide whether or not he wants his cancer to be treated with chemotherapy. If the patient undergoes chemotherapy, the chance of having the tumor
growth stopped without recurrence will be 70%. Refraining from treatment on the other hand will likely result in death within a few months. There are no other pertinent
treatment options. The patient's medical decision-making capacity is doubted and needs further examination.
In which case do you apply higher standards in terms of mental abilities for assessing medical decision-making capacity?
1) The patient chooses to undergo chemotherapy.
2) The patient chooses not to undergo chemotherapy (treatment refusal).
3) In both cases, I apply equally stringent standards in terms of mental abilities.
Assisted suicide
The same patient (from the chemotherapy vignette above) decided not to undergo chemotherapy (treatment refusal). Instead he asks for assisted suicide.
You are consulted to evaluate the patient’s medical decision-making capacity.
Which standards must be fulfilled to deem the patient capable?
1) I apply more stringent standards in terms of mental abilities as in the case of treatment refusal.
2) I apply equally stringent standards in terms of mental abilities as in the case of treatment refusal.
3) I must be personally convinced that assisted suicide is the best option available for the patient.
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ments are in most cases never (38.6%; n = 200) or rarely
(22%; n = 114) disclosed as such to the patient.
Physicians who evaluate DMC explicitly apply the follow-
ing methods: unstructured interview with own situation-
specific questions (92.8%, n = 476); semi-structured inter-
view with partly predetermined questions (8.6%, n = 44);
standardised interview with precisely determined questions
(7%, n = 36); questionnaire or written test (15%, n = 77);
and non-written test procedure (6.4%, n = 33).
A closer look at the instruments which physicians listed
in an open-ended format revealed that they primarily use
tools that were originally designed for dementia assess-
ments, of which the most prominent named in this survey
is the Mini Mental State Examination (MMSE; [16]). In-
struments which are specifically designed for the assess-
ment of DMC are used by only a few physicians (2.5%, n
= 15), and most have never heard of such specific instru-
ments as the Mac Arthur Competence Assessment Tool for
Treatment (72.3%, n = 552; MacCAT-T, [17]); the Aid to
Capacity Evaluation (77.2%, n = 589; ACE, [18]); and Sil-
berfeld’s Competence Tool (84%, n = 614; [19]).
Demand for assessment tools, guidelines, and training
Despite physicians’ lack of knowledge about and actual use
of DMC assessment tools, most physicians indicated an in-
terest in such instruments. More than half of physicians
would appreciate a certain form of standardisation (65.8%,
n = 502), and official guidelines and more extensive train-
ing in systematic DMC evaluations were also clearly con-
sidered useful. However, approximately a third of all re-
sponding physicians indicated that they would not use any
of the proposed tools (32%, n = 244) (see table 7).
Discussion
The aim of the present study was to gain more insight into
the attitudes, knowledge, and assessment practices of phys-
icians in Switzerland with regard to DMC. The survey yiel-
Table 4: Complicating factors in DMC evaluations.
Cases of marginal capacity or a “grey area” case between obvious capacity and obvious
incapacity
69.1% (n = 527)
A very complicated ethical situation 54.5% (n = 416)
Chaotic/ conflicting family situation 46.8% (n = 357)
Patient factors (e.g., lack of willingness to cooperate) 37.5% (n = 286)
Legal situation unclear 24.8% (n = 189)
Disagreement with other treating physicians or the care team 23.6% (n = 180)
Unclear how to apply risk/benefit consideration into the final evaluation 22.7% (n = 173)
None of the mentioned aspects 0.5% (n = 4)
Table 5: Strategies for enhancing DMC: Importance and feasibility in every day practice.
Considered as
relevant strategy
Implementation
mostly feasible
Implementation not or
restricted feasible
I defer the capacity evaluation to a later point in time if the patient appears to be in bad
shape.
88.1% (n = 672) 38.3% (n = 292) 49.8% (n = 380)
I align the disclosed information to patients’ needs (e.g., additional written information,
diagrams and illustrations, translations).
97.1% (n = 741) 68.5% (n = 523) 28.6% (n = 218)
I change medication which might influence patient’s mental abilities. 82.7% (n = 631) 26.9% (n = 205) 55.8% (n = 426)
I encourage the patient to discuss the upcoming decision with a close person. 97.1% (n = 741) 76.3% (n = 582) 20.8% (n = 159)
I give the patient the chance to be accompanied by someone close. 96.6% (n = 737) 78.8% (n = 601) 17.8% (n = 136)
I especially make sure that the dialogue takes place in a relaxed and comfortable
atmosphere.
98.0% (n = 748) 78.6% (n = 600) 19.4% (n = 148)
I acknowledge and discuss psychological aspects like anxiety and avoidance tendencies, or
carry out short psychotherapeutic interventions.
90.1% (n = 688) 38.4% (n = 293) 51.7% (n = 395)
Table 6: Frequency of implicit and explicit DMC evaluations and of referrals.
Often or always
Implicit
within the scope of the regular consultation
63.5% (n = 484)
Explicit
extra time and space during the consultation
36.6% (n = 279)
Referral
consultation of specialised colleagues
51.1% (n = 390)
Table 7: Request for guidance: Assessment tools, guidelines, and training.
Assessment tools (multiple answer options) Guidelines Training
Semi-structured interview
with partly predetermined questions
40.9% (n = 312) Not at all useful 4.7% (n = 36) 0.7% (n = 5)
Standardised interview
with precisely determined questions
25.7% (n = 196) Rather not useful 10% (n = 76) 4.2% (n = 32)
Questionnaire or written test 19.4% (n = 148) Rather useful 46.9% (n = 358) 41.4% (n = 316)
Non-written test procedure 15.2% (n = 116) Very useful 36.7% (n = 280) 52.8% (n = 403)
None of the mentioned aids 32% (n = 244)
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ded wide-ranging results, among which particular elements
deserve further attention as they highlight unresolved con-
ceptual challenges or point to areas requiring further im-
provement, especially from a practical or policy perspect-
ive.
In general, the survey demonstrates that the concept of
DMC and its assessment, far from being trivial, is an issue
of major importance. This is reflected, first, in the discord
concerning any general conceptual understanding. It is
reasonable to say that DMC is both a dichotomous concept
and something gradual. DMC evaluations are challenging
because they require the evaluating physician to assess
characteristics of the patient which are gradual in nature
and to then integrate them in a clear action-guiding judge-
ment.
With respect to patient characteristics, the survey results in-
dicated that physicians in Switzerland have a more nuanced
understanding of relevant mental abilities than is sugges-
ted by the prevailing academic account. As well as un-
derstanding the relevance of cognitive abilities, they also
acknowledge the importance of emotional, intuitive, and
evaluative processes. This finding, together with theoretic-
al arguments for the inclusion of non-cognitive elements,
points to the need for further reflection on how to system-
atically incorporate these elements into DMC assessments
[7].
Furthermore, the results show that physicians in Switzer-
land agree with experts in the field that various factors bey-
ond knowledge of patients’ mental abilities contribute to
judgements about DMC. Of particular interest in this re-
gard is the impact of the physician’s own set of values: a
quarter of all participants regarded their values as rather
or very important. This may be positively interpreted as a
critical awareness of personal biases. Experts in the field
generally recognise that DMC evaluations are inherently
normative and, therefore, never totally objective – a fact
that makes DMC evaluation even more complex and, per-
haps, susceptible to unjustified medical paternalism [20].
Responses to the case vignette on assisted suicide allude
to that problem. Though in the minority, there were physi-
cians who said that they would have to be personally con-
vinced that assisted suicide was the best option available
for the patient as a criterion for deeming the patient cap-
able. Certainly, physicians are allowed to have different at-
titudes towards assisted suicide and to refuse assistance;
however, it seems unduly paternalistic to deem the patient
incompetent because of one’s personal convictions that as-
sisted suicide is not a justifiable option. In this case, physi-
cians’ values pertain directly to the outcome of the patient’s
choice, and there is agreement that DMC evaluation should
not be based on the decisional outcome but rather on the
decision-making process [1].
In terms of risk-relativity, the outcome also plays a role,
but in a different sense, determining the requirements for
patients’ mental abilities in regard to the decision-making
process. It goes beyond the scope of this article to discuss
whether or not risk-relativity is appropriate, but physicians’
attitudes indicate that this is indeed a very complex issue.
A discrepancy was found between physicians’ general at-
titude towards risk-relativity and their respective attitudes
within a specific situation. A high proportion of those who
would evaluate DMC at least in part on the basis of con-
sequences arising from the patient’s choice refrained from
applying that attitude in response to the specific case vign-
ette. One possible explanation for this result might be that
the asymmetry (the patient is competent to consent, but in-
competent to refuse treatment), which in risk-relative as-
sessments appears somehow counterintuitive, was much
more obvious in the vignette [21]. Further analyses and
discussion of risk-relativity, especially in relation to physi-
cians’ personal values, are presented elsewhere [22].
In terms of decisional relativity, it has been shown that al-
most half of all participants do not agree with the statement
that DMC is dependent on the specific decision. However,
it remains unclear whether this is due to a knowledge defi-
cit or to concerns about feasibility.
Looking at physicians’ evaluation practices with regard to
different patient groups, it is worth mentioning that they
do conduct detailed DMC assessments relatively often with
healthy elderly persons and patients at the end of life. The
comparable high scores may be related to the high preval-
ence of such patients in clinical practice and not strictly to
the specific characteristics of patients; because of a lack of
precision in the question, this cannot be conclusively con-
firmed. Nevertheless, the results indicate that these patients
are affected by incompetence, and that more research is
needed, especially as patients in these categories are some-
what neglected in the current DMC literature. One ques-
tion of particular interest concerns the extent to which the a
priori assumption of competence implicitly turns into a de-
fault presumption of incompetence in such patient groups.
One of the most intriguing results of this survey, which
has important policy implications, is the finding of a dis-
crepancy between physicians’ felt responsibility for con-
ducting DMC evaluations and their qualification for the
task, in combination with a related request for more guid-
ance in this area in form of official guidelines, continuing
education and training, and/or assessment tools. It appears
that physicians in Switzerland currently apply their own
rules of thumb, acquired over time and perhaps proven to
be clinically appropriate, but also evoking feelings of un-
certainty. The high frequency of implicit assessments and
the use of unstructured interviews with physicians’ own
situation-specific questions may be seen to support such an
explanation. In terms of guidelines, education, and train-
ing, it would seem important not only to introduce physi-
cians to the complex conceptual challenges around DMC,
but also to remedy obvious knowledge deficits concerning
existing assessment tools, and to sensitise and train them
in handling practical challenges regarding how to deal, for
example, with complicating factors, or how to effectively
enhance patients’ DMC.
Finally from an ethical point of view, further reflections on
the moral dimensions of DMC evaluations seem crucial.
Although clarity with regard to relevant criteria for DMC
as well as valid and reliable assessments of patient charac-
teristics are important, they do not give a concluding an-
swer to the question of whether or not the patient is com-
petent. This rests eventually on a normative judgement that
includes a weighing of moral principles, and thus, relies on
values and norms pertaining not only to the society at large
but also to the individual evaluator [22]. Therefore, further
Original article Swiss Med Wkly. 2014;144:w14039
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reflections are needed on the moral status of such influen-
cing factors, and the way physicians may be supported in
arriving at a final judgement.
Limitations
In light of the response rate of 22.15%, the representat-
iveness of the sample is clearly restricted. Although the
sample characteristics are, in most regards, comparable
to those of the population of physicians in Switzerland
(see [14]), there is a clear over-representation of hospital
physicians. In terms of medical specialisms, anaesthesiolo-
gists, surgeons, and neurologists are over-represented, and
general medical practitioners are clearly under-represen-
ted. Moreover, self-selection may also have been a relevant
factor to the extent that physicians with a particular need
or interest in the topic were more likely to respond. It fol-
lows that an overestimation, specifically in terms of desired
guidance, cannot be ruled out.
Conclusion
The conceptual and practical challenges of DMC are far
from being resolved. There is a clear need for more guid-
ance in this area in the form of guidelines, tools, and train-
ing. To this end, further discussion and education would be
desirable within the concerned medical associations and or-
ganisations.
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